These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8571333)

  • 1. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor.
    Schini-Kerth VB; Fisslthaler B; Andersen TT; Fenton JW; Vanhoutte PM; Busse R
    Thromb Haemost; 1995 Sep; 74(3):980-6. PubMed ID: 8571333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
    Hecker M; Preiss C; Schini-Kerth VB
    Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor-mediated inhibition of cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells.
    Nakayama I; Kawahara Y; Okuda M; Yokoyama M
    Blood Press Suppl; 1994; 5():32-7. PubMed ID: 7534178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase in vascular smooth muscle.
    Schini VB; Busse R; Vanhoutte PM
    Arzneimittelforschung; 1994 Mar; 44(3A):432-5. PubMed ID: 7514415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
    Schini VB; Catovsky S; Durante W; Scott-Burden T; Schafer AI; Vanhoutte PM
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H611-6. PubMed ID: 7680540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10.
    Ruetten H; Thiemermann C
    Shock; 1997 Dec; 8(6):409-14. PubMed ID: 9421853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin increases nitric oxide synthesis in IL-1 beta-stimulated smooth muscle cells.
    Chen H; Xing Y; Liu R
    Chin Med J (Engl); 2001 Nov; 114(11):1123-7. PubMed ID: 11729502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
    Weber AA; Seul C; Harth V; Ko Y; Seewald S; Vetter H; Sachinidis A
    Br J Pharmacol; 1998 Mar; 123(5):906-10. PubMed ID: 9535019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2.
    Welch GN; Upchurch GR; Farivar RS; Pigazzi A; Vu K; Brecher P; Keaney JF; Loscalzo J
    Proc Assoc Am Physicians; 1998; 110(1):22-31. PubMed ID: 9460080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hypoxia on nitric oxide production and its synthase gene expression in rat smooth muscle cells.
    Hong Y; Suzuki S; Yatoh S; Mizutani M; Nakajima T; Bannai S; Sato H; Soma M; Okuda Y; Yamada N
    Biochem Biophys Res Commun; 2000 Feb; 268(2):329-32. PubMed ID: 10679203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-beta.
    Maggi A; Cignarella A; Brusadelli A; Bolego C; Pinna C; Puglisi L
    Circulation; 2003 Jul; 108(2):211-7. PubMed ID: 12821541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III enhances inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Totzke G; Smolny M; Seibel M; Czechowski M; Schobersberger W; Hoffmann G
    Cell Immunol; 2001 Feb; 208(1):1-8. PubMed ID: 11277613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins.
    Durante W; Kroll MH; Orloff GJ; Cunningham JM; Scott-Burden T; Vanhoutte PM; Schafer AI
    Biochem Pharmacol; 1996 Mar; 51(6):847-53. PubMed ID: 8602881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.
    Pingle SC; Sanchez JF; Hallam DM; Williamson AL; Maggirwar SB; Ramkumar V
    Mol Pharmacol; 2003 Jun; 63(6):1238-47. PubMed ID: 12761333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of inducible nitric oxide synthase (iNOS) and GTP cyclohydrolase I (GTP-CH I) gene expression by ox-LDL in rat vascular smooth muscle cells.
    Dulak J; Polus M; Guevara I; Polus A; Hartwich J; Dembińska-Kieć A
    J Physiol Pharmacol; 1997 Dec; 48(4):689-97. PubMed ID: 9444617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
    Schini VB; Catovsky S; Schray-Utz B; Busse R; Vanhoutte PM
    Circ Res; 1994 Jan; 74(1):24-32. PubMed ID: 7505207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of protein kinase C alpha enhances lipopolysaccharide-induced nitric oxide formation in vascular smooth muscle cells.
    Li S; Huang FL; Feng Q; Liu J; Fan SX; McKenna TM
    J Cell Physiol; 1998 Aug; 176(2):402-11. PubMed ID: 9648928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
    Ma J; Kishida S; Wang GQ; Meguro K; Imuta H; Oonuma H; Iida H; Jo T; Takano H; Morita T; Nagai R; Nakajima T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):314-21. PubMed ID: 16495772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the L-arginine-nitric oxide pathway in vascular smooth muscle.
    Schini VB; Vanhoutte PM
    Eur Heart J; 1993 Nov; 14 Suppl I():16-21. PubMed ID: 7507437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inducible nitric oxide synthase is impaired by thrombin in vascular smooth muscle cells.
    Schini VB; Catovsky S; Scott-Burden T; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S142-4. PubMed ID: 1282951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.